PTEN
PTEN is the cells primary metabolic brake, a master tumor suppressor that directly opposes the growth signals of insulin and PI3K. By converting the signaling lipid PIP3 back into its inactive form, it coordinates cellular rest and repair; while its loss is a universal driver of aggressive cancer, its experimental elevation is one of the most effective known methods for increasing both healthspan and longevity.
Key Takeaways
- •PTEN is the master off-switch for growth signaling, physically opposing the action of PI3K.
- •It acts as a metabolic rheostat, deciding whether a cell should spend energy on growth or maintenance.
- •Loss of PTEN is one of the most common events in human cancer, removing the "brake" on cell division.
- •In the brain, PTEN is essential for wiring; mutations here are a significant cause of macrocephaly and autism.
- •Experimental "Super-PTEN" models show that slightly higher PTEN levels lead to exceptional longevity and cancer resistance.
Basic Information
- Gene Symbol
- PTEN
- Full Name
- Phosphatase and Tensin Homolog
- Also Known As
- pRbRBp105-RbPPP1R130
- Location
- 10q23.31
- Protein Type
- Phosphatase
- Protein Family
- PTP family
Related Isoforms
The canonical 403-amino acid protein that acts as a tumor suppressor.
A secreted form of PTEN that can enter neighboring cells to suppress growth.
Key SNPs
Common regulatory variant; the C allele is associated with increased risk of breast and colorectal cancers.
C allele linked to general cancer susceptibility; A allele associated with better prognosis in lung cancer.
Associated with increased risk of hepatocellular carcinoma (liver cancer) in GWAS.
Linked to breast and esophageal cancer risk, particularly in East Asian populations.
High-impact pathogenic variant associated with Cowden Syndrome and Autism with macrocephaly.
Known pathogenic variant linked specifically to Macrocephaly-Autism Syndrome.
Overview
PTEN (Phosphatase and Tensin Homolog) is arguably the most important "brake" in the human body. It is a dual-specificity phosphatase, an enzyme whose primary job is to undo the work of the growth-promoting enzyme PI3K. While PI3K creates the signaling lipid PIP3 to trigger growth, PTEN immediately converts it back to PIP2, effectively silencing the signal.
Because it sits at the very heart of the insulin and growth factor signaling pathway, PTEN is a master regulator of cellular energy use. When PTEN is active, the cell enters a state of maintenance, repair, and recycling (autophagy). When PTEN is lost or suppressed, the cell is locked in a state of permanent growth and "anabolic" metabolism—the foundational environment for both cancer and accelerated biological aging.
Conceptual Model
A simplified mental model for the pathway:
PTEN maintains cellular balance by ensuring growth signals are only temporary.
Core Health Impacts
- • Metabolic Brake: Master off-switch for insulin-driven lipid and protein synthesis.
- • Tumor Suppression: Foundational safeguard against the development of most solid tumors.
- • Stem Cell Guard: Essential for maintaining the "resting" state of stem cells to prevent exhaustion.
- • Genome Security: Nuclear PTEN coordinates the repair of double-strand DNA breaks.
- • Neural Wiring: Regulates the size and connectivity of neurons during brain development.
- • Longevity Driver: dosage is a primary determinant of healthspan across species.
Protein Domains
Phosphatase Domain
The catalytic heart that removes phosphates from lipids (PIP3) and proteins (FAK).
C2 Domain
The "anchor" that binds to the cell membrane, allowing the phosphatase to reach its target.
C-Terminal Tail
Rich in phosphorylation sites that regulate PTEN stability and trafficking.
Upstream Regulators
p53 Activator
Transcriptional activator; upregulates PTEN in response to DNA damage to halt the cell cycle.
PPAR-gamma Activator
Nuclear receptor that induces PTEN expression, linking metabolic state to tumor suppression.
EGR1 Activator
Transcription factor that directly binds the PTEN promoter to increase its cellular levels.
NEDD4-1 Modulator
E3 ligase that controls PTEN monoubiquitination, facilitating its essential nuclear trafficking.
miR-21 Inhibitor
Oncogenic microRNA that silences PTEN mRNA, effectively removing the brake.
WWP1 Inhibitor
E3 ligase that tags PTEN for degradation; inhibited by compounds like I3C.
Downstream Targets
PIP3 Inhibits
Primary lipid substrate; PTEN dephosphorylates PIP3 to PIP2, directly opposing PI3K signaling.
AKT1 Inhibits
Indirectly inhibited by PTEN via PIP3 reduction, which prevents AKT membrane recruitment.
FAK (Focal Adhesion Kinase) Inhibits
Protein substrate; dephosphorylation inhibits cell migration and prevents tumor metastasis.
FOXO transcription factors Activates
PTEN maintains FOXO in the nucleus (active), promoting antioxidant defense and DNA repair.
mTORC1 Inhibits
Inhibited indirectly via the AKT-TSC2 axis, leading to reduced protein synthesis and increased autophagy.
RAD51 Activates
Nuclear PTEN promotes RAD51 expression to facilitate accurate double-strand break repair.
Role in Aging
PTEN is a causal driver of healthy longevity. By enforcing a "maintenance first" cellular priority, it ensures that resources are not constantly diverted to growth at the expense of repair.
Nutrient Sensing Check
PTEN sets the threshold for nutrient-driven signaling. Higher PTEN tone promotes a maintenance state similar to caloric restriction.
Proteostasis & Autophagy
By inhibiting mTORC1 and activating FOXO, PTEN promotes the turnover of damaged proteins and organelles.
Super-PTEN Longevity
Animal models with extra copies of PTEN live longer, have better metabolic health, and are highly resistant to cancer.
Genomic Integrity
Nuclear PTEN protects against the accumulation of mutations. This role is critical for long-term healthspan.
Metabolic Flexibility
Balanced PTEN activity supports insulin sensitivity. Age-related loss contributes to the metabolic dysfunction of old age.
Stem Cell Quiescence
PTEN is essential for keeping stem cells in a resting state. Loss of PTEN leads to stem cell exhaustion.
Disorders & Diseases
Cancer & Neoplasia
Somatic loss of PTEN is a hallmark of many aggressive cancers. Without the PTEN brake, tumors achieve limitless replicative potential.
PTEN Hamartoma Tumor Syndrome (PHTS)
Includes Cowden Syndrome. Germline mutations lead to multiple benign growths and high lifetime risk of several cancers.
Autism & Macrocephaly
PTEN mutations are found in 10-20% of children with both autism and enlarged head size (macrocephaly).
Lhermitte-Duclos Disease
A rare tumor of the cerebellum driven by localized loss of PTEN function.
Interventions
Supplements
Found in broccoli; inhibits the WWP1 enzyme to prevent PTEN degradation and restore its function.
Polyphenol that enhances PTEN membrane association and activity through acetylation modulation.
Turmeric extract reported to upregulate PTEN expression and inhibit PI3K/AKT signaling.
May potentiate PTEN activity and expression, supporting cardiovascular and metabolic health.
Flavonoid that has shown the ability to restore PTEN levels and promote apoptosis in aberrant cells.
Lifestyle
Downregulates IGF-1/Insulin signaling, creating a state where PTEN-mediated checks are most effective.
Improves insulin sensitivity; regular activity helps maintain a healthy PI3K-PTEN rheostat.
Provides I3C and sulforaphane which protect PTEN from being tagged for degradation by E3 ligases.
Cortisol interacts with PTEN to stabilize glucocorticoid receptors; chronic stress can dysregulate this balance.
Medicines
Can increase PTEN expression via PPAR-gamma activation, contributing to their anti-cancer effects.
PPAR-gamma agonists that upregulate PTEN to improve metabolic signaling.
Promote PTEN acetylation and membrane translocation, enhancing its tumor-suppressive capacity.
Pharmacological agents that mimic PTEN function by blocking PIP3 production upstream.
Lab Tests & Biomarkers
Genetic Testing
Crucial for diagnosing Cowden Syndrome and assessing hereditary cancer risk.
Sequencing of tumor biopsy to identify PTEN deletions or mutations.
Includes PTEN as a top-tier gene for children with large head circumference and autism.
Activity Markers
Staining of tumor tissue to verify if PTEN protein is physically present or lost.
High levels often indicate a loss of PTEN function, as the brake is no longer checking AKT.
Metabolic Markers
Loss of PTEN pathway integrity contributes to the progression of insulin resistance.
Estimate of insulin resistance; a high score suggests overactive nutrient signaling.
Hormonal Interactions
Insulin Primary Target
PTEN dephosphorylates PIP3 to shut down the insulin-induced AKT survival and growth pathway.
IGF-1 Growth Antagonist
PTEN suppresses IGF-1-mediated mitogenesis by checking downstream PI3K signaling.
Cortisol Stability Regulator
PTEN stabilizes the Glucocorticoid Receptor; PTEN loss can lead to cortisol resistance.
Estrogen Regulatory Inhibitor
Can rapidly inhibit PTEN via phosphorylation, driving rapid cell proliferation.
Progesterone Cyclical Balancer
Counteracts estrogen by promoting PTEN expression in the endometrium.
Deep Dive
Network Diagrams
The PTEN/PI3K Rheostat Cycle
PTEN Stability Circuit
The PI3K-PTEN Rheostat: Balancing Growth and Repair
In every cell, there is a constant tension between the “gas pedal” (PI3K) and the “brake” (PTEN). This cycle is the fundamental rheostat of life.
- The PIP3 Beacon: When PI3K is activated by insulin, it creates a lipid molecule called PIP3. Think of PIP3 as a beacon that recruits survival proteins like AKT to the cell surface.
- The Reset: PTEN sits at the membrane and constantly “scrapes” the PIP3 beacons away, converting them back into the inactive PIP2.
- The Health Threshold: If PTEN is weak, the PIP3 signal lingers too long, leading to chronic over-growth and metabolic dysfunction. If PTEN is strong, the cell maintains its sensitivity to signals but returns quickly to a state of repair and cleaning (autophagy).
Nuclear PTEN and the Genome Guard
While most people focus on PTEN at the cell membrane, its role inside the nucleus is equally vital for long-term healthspan. Loss of nuclear PTEN is a frequent marker of advanced aging and genomic instability.
Inside the nucleus, PTEN acts as a quality control manager for DNA. It ensures that the protein RAD51 is available to repair double-strand breaks in the genome. It also physically interacts with the centromeres of chromosomes to ensure that when a cell divides, each new cell gets exactly the right amount of DNA. Without nuclear PTEN, the genome slowly “drifts” into a state of chaos, accumulating the mutations that drive age-related decline.
Super-PTEN: A Secret to Extreme Longevity
A breakthrough in longevity research occurred when scientists created “Super-PTEN” mice—animals engineered to have extra copies of the PTEN gene.
- Superior Healthspan: These mice didn’t just live longer (though they did); they were healthier. They had a significant resistance to cancer and, surprisingly, were much thinner and more insulin-sensitive than normal mice.
- Metabolic Power: The extra PTEN forced their cells to prioritize mitochondrial efficiency and internal cleaning over rapid division. This demonstrates that PTEN is not just a gene that “stops cancer,” but a master controller that can actually slow down the rate of biological aging itself.
Interpreting PTEN Status
Haploinsufficiency. PTEN is dose-sensitive. Even losing just one copy (50% level) can significantly increase cancer risk.
Dietary Leverage. Compounds like I3C from broccoli can help keep the PTEN "brake" from being degraded.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
The landmark discovery paper identifying PTEN as a major tumor suppressor.
Established the mechanism: PTEN dephosphorylates PIP3 to inhibit AKT.
Demonstrated that "Super-PTEN" mice have increased longevity and superior metabolic health.
Showed that PTEN is essential for stem cell quiescence.
Revealed the structure explaining PTEN preference for lipid substrates.
Discovered PTEN-Long, a version of PTEN that acts as a circulating tumor suppressor.